205
Participants
Start Date
September 30, 2013
Primary Completion Date
July 31, 2014
Study Completion Date
September 30, 2014
TNX-102 SL 2.8mg
Patients will take 1 tablet of randomly assigned study drug sublingually each day at bedtime starting on Day 0 for 12 weeks.
Placebo
Patients will take 1 tablet of randomly assigned study drug sublingually each day at bedtime starting on Day 0 for 12 weeks.
1001 South Market Street, Mechanicsburg
71 Thomas Johnson Drive, Frederick
322 Memorial Drive, Greer
100 West Gore Street, Orlando
16176 Cortez Boulevard, Brooksville
CRC of Jackson, LLC, Jackson
1275 Olentangy River Road, Columbus
18660 Bagley Road, Middleburg Heights
University of Cincinnati College of Medicine, Cincinnati
3401 North Central Avenue, Chicago
Radiant Research, Inc., Denver
1002 E. South Temple, Salt Lake City
107 Scripps Drive, Sacramento
1951 152nd Place NE, Bellevue
601 Broadway, Seattle
370 Faunce Corner Road, North Dartmouth
Clinical Pharmacology Study Group, Worcester
Tonix Pharmaceuticals, Inc.
INDUSTRY